Data / Form D filings / Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc.: Form D filings
Hepion Pharmaceuticals, Inc., a biotechnology company in Red Bank, NJ, filed 9 Form D notices with the SEC between 2014 and 2026. The latest, on August 5, 2026, reports $3.1 million sold of a $3.1 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 34 SHREWSBURY AVE. SUITE 1D, Red Bank, NJ, 07701
- Phone
- (732) 902-4000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1583771
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | New notice | $3,055,000 | $3,055,000 | 33 | Jul 31, 2026 | sec.gov | |
| Apr 22, 2026 | New notice | $700,000 | $700,000 | 11 | Apr 21, 2026 | sec.gov | |
| Jul 24, 2024 | New notice | $2,900,000 | $2,900,000 | 7 | Jul 19, 2024 | sec.gov | |
| Oct 3, 2023 | New notice | $5,000,004 | $5,000,004 | 1 | Sep 28, 2023 | sec.gov | |
| Nov 15, 2022 | New notice | $20,000,000 | $20,000,000 | 8 | Nov 4, 2022 | sec.gov | |
| Mar 27, 2019 | New notice | $1,250,000 | $1,250,000 | 1 | Mar 13, 2019 | sec.gov | |
| Oct 23, 2014 | New notice | $12,500,000 | $9,000,000 | $3,500,000 | 1 | Oct 14, 2014 | sec.gov |
| Aug 22, 2014 | New notice | $4,742,648 | $4,742,648 | 19 | Aug 20, 2014 | sec.gov | |
| Feb 14, 2014 | New notice | $3,225,000 | $3,225,000 | 19 | Feb 4, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary Stetz | Executive Officer, Director | Interim Chief Executive Officer |
| Vincent LoPriore | Executive Officer, Director | Executive Chairman |
| Sireesh Appajosyula | Director | |
| Chase LoPriore | Director | |
| Michael Purcell | Director | |
| Dania Fisher | Director | |
| Gary S. Stetz, II | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hepion Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.